The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivitydisorder
B. Spivak et al., The influence of three months of methylphenidate treatment on platelet-poor plasma biogenic amine levels in boys with attention deficit hyperactivitydisorder, HUM PSYCHOP, 16(4), 2001, pp. 333-337
Citations number
24
Categorie Soggetti
Neurosciences & Behavoir
Journal title
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
Attention deficit hyperactivity disorder (ADHD) is related to dysregulation
in the activity of brain monoamines. The aim of the present study was to a
ssess the impact of three months' methylphenidate (MPH) treatment on platel
et-poor plasma (PPP) norepinephrine (NE), dopa and serotonin (5-MT) levels
as well as on ADHD symptomatology. Three months of MPH treatment in 16 ADHD
boys, aged 11.4 +/- 1.6 years, resulted in a significant reduction in PPP
NE levels (p < 0.05). A tendency towards a reduction of PPP 5-HT and dopa l
evels was detected (p < 0.1 for both). The decrease in PPP biogenic amine l
evels after three months of MPH treatment was accompanied by a significant
reduction in all psychometric characteristics of ADHD. This result indicate
s the possible role of overactivity of the noradrenergic system in the path
ophysiology of ADHD and suggests that the MPH therapeutic action may be rel
ated to stimulant-induced inhibitory effect on the noradrenergic system. Co
pyright (C) 2001 John Wiley & Sons, Ltd.